Amylyx Pharmaceuticals, Inc. (AMLX) Tops Q4 EPS by 4c

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) reported Q4 EPS of ($0.30), $0.04 better than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Amylyx Pharmaceuticals, Inc. (AMLX) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
• AMD (AMD) call put ratio 1 call to 1.8 put with a focus on August 28 weekly 305 puts